Is Bacil Pharma Ltd. a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Bacil Pharma Ltd. and arrived at the following conclusion.

Is the current market price of Bacil Pharma Ltd. a good price to buy it?

The 5-year analysis of Bacil Pharma Ltd.'s performance infers.

What is Bacil Pharma Ltd. share price return in the past 10 years?

We analysed the performance of Bacil Pharma Ltd. share prices over the last 10 years. Here is what we found out:

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Bacil Pharma Ltd.

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

What is CAGR? What does CAGR table indicate for Bacil Pharma Ltd.?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Bacil Pharma informs about quarterly statement on investor complaints

Bacil Pharma Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 524516 | NSE:

19 Oct 2016

Evaluate

Bacil Pharma has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Related Bacil Pharma Ltd. Links:

Analysis

Reports

News

Stock Price

Sector News